These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31779673)

  • 1. Osteogenic commitment of Wharton's jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application.
    Cabrera-Pérez R; Monguió-Tortajada M; Gámez-Valero A; Rojas-Márquez R; Borràs FE; Roura S; Vives J
    Stem Cell Res Ther; 2019 Nov; 10(1):356. PubMed ID: 31779673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Wharton's jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment.
    Cabrera-Pérez R; Ràfols-Mitjans A; Roig-Molina Á; Beltramone S; Vives J; Batlle-Morera L
    J Transl Med; 2023 Nov; 21(1):802. PubMed ID: 37950242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
    Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
    Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.
    Donders R; Bogie JFJ; Ravanidis S; Gervois P; Vanheusden M; Marée R; Schrynemackers M; Smeets HJM; Pinxteren J; Gijbels K; Walbers S; Mays RW; Deans R; Van Den Bosch L; Stinissen P; Lambrichts I; Gyselaers W; Hellings N
    Stem Cells Dev; 2018 Jan; 27(2):65-84. PubMed ID: 29267140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic context.
    Reppel L; Margossian T; Yaghi L; Moreau P; Mercier N; Leger L; Hupont S; Stoltz JF; Bensoussan D; Huselstein C
    Curr Stem Cell Res Ther; 2014; 9(4):306-18. PubMed ID: 24524785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.
    Raicevic G; Najar M; Pieters K; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Tissue Eng Part A; 2012 Jul; 18(13-14):1410-8. PubMed ID: 22429150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
    Hsieh JY; Fu YS; Chang SJ; Tsuang YH; Wang HW
    Stem Cells Dev; 2010 Dec; 19(12):1895-910. PubMed ID: 20367285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.
    Datta I; Mishra S; Mohanty L; Pulikkot S; Joshi PG
    Cytotherapy; 2011 Sep; 13(8):918-32. PubMed ID: 21696238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Proteomic Analysis of the Mesenchymal Stem Cells Secretome from Adipose, Bone Marrow, Placenta and Wharton's Jelly.
    Shin S; Lee J; Kwon Y; Park KS; Jeong JH; Choi SJ; Bang SI; Chang JW; Lee C
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34(+) Transplants.
    van der Garde M; van Pel M; Millán Rivero JE; de Graaf-Dijkstra A; Slot MC; Kleinveld Y; Watt SM; Roelofs H; Zwaginga JJ
    Stem Cells Dev; 2015 Nov; 24(22):2649-59. PubMed ID: 26414086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.
    Drela K; Lech W; Figiel-Dabrowska A; Zychowicz M; Mikula M; Sarnowska A; Domanska-Janik K
    Cytotherapy; 2016 Apr; 18(4):497-509. PubMed ID: 26971678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells.
    Balasubramanian S; Venugopal P; Sundarraj S; Zakaria Z; Majumdar AS; Ta M
    Cytotherapy; 2012 Jan; 14(1):26-33. PubMed ID: 22091833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteogenic differentiation of human mesenchymal stem cells from adipose tissue and Wharton's jelly of the umbilical cord.
    Zajdel A; Kałucka M; Kokoszka-Mikołaj E; Wilczok A
    Acta Biochim Pol; 2017; 64(2):365-369. PubMed ID: 28600911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly.
    Amable PR; Teixeira MV; Carias RB; Granjeiro JM; Borojevic R
    Stem Cell Res Ther; 2014 Apr; 5(2):53. PubMed ID: 24739658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity.
    Anzalone R; Lo Iacono M; Corrao S; Magno F; Loria T; Cappello F; Zummo G; Farina F; La Rocca G
    Stem Cells Dev; 2010 Apr; 19(4):423-38. PubMed ID: 19958166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenic differentiation of Wharton's jelly-derived mesenchymal stem cells cultured on WJ-scaffold through conventional signalling mechanism.
    Beiki B; Zeynali B; Taghiabadi E; Seyedjafari E; Kehtari M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1032-S1042. PubMed ID: 30449193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An
    Aslam N; Abusharieh E; Abuarqoub D; Alhattab D; Jafar H; Alshaer W; Masad RJ; Awidi AS
    Pathol Oncol Res; 2021; 27():584710. PubMed ID: 34257532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Netrin-1 acts as a non-canonical angiogenic factor produced by human Wharton's jelly mesenchymal stem cells (WJ-MSC).
    Prieto CP; Ortiz MC; Villanueva A; Villarroel C; Edwards SS; Elliott M; Lattus J; Aedo S; Meza D; Lois P; Palma V
    Stem Cell Res Ther; 2017 Feb; 8(1):43. PubMed ID: 28241866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.